HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PF-2341066

exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
Networked: 9 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Christensen, James G: 5 articles (02/2011 - 05/2007)
2. McDonnell, Scott R: 2 articles (12/2007 - 05/2007)
3. Lee, Joseph H: 2 articles (12/2007 - 05/2007)
4. Zou, Helen Y: 2 articles (12/2007 - 05/2007)
5. Yamazaki, Shinji: 2 articles (12/2007 - 05/2007)
6. Li, Qiuhua: 2 articles (12/2007 - 05/2007)
7. Los, Gerrit: 2 articles (12/2007 - 05/2007)
8. Mroczkowski, Barbara: 2 articles (12/2007 - 05/2007)
9. Arango, Maria E: 2 articles (12/2007 - 05/2007)
10. Doyle, Lisa: 1 article (12/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. Neoplasm Metastasis (Metastasis)
4. Ovarian Neoplasms (Ovarian Cancer)
5. Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)

Related Drugs and Biologics

1. Adenosine Triphosphate (ATP)
2. 5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- one
3. Matrix Metalloproteinases
4. anaplastic lymphoma kinase

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)